Charles Explorer logo
🇬🇧

Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European cohort

Publication at First Faculty of Medicine |
2010

Abstract

The use of a panel of anticarbohydrate antibodies may provide additional help in distinguishing IBD from non-IBD disease patterns. The addition of AMCA, ALCA, and ACCA assays as IBD serology markers improves the overall sensitivity of immunological examinations in IBD; however, anticarbohydrate assays are not helpful for predicting CD behavior.